David Kallend

David Kallend has over 30 years of experience in the pharmaceutical industry. David began their career in 1988 as a House Officer at St Helier Hospitals. In 1989, they became a Research Fellow at the Royal Postgraduate Medical School. In 1995, they were an International Clinical Research Physician at Schering. From 1998 to 2005, they were a Medical Advisor and Lead Global Brand Physician at AstraZeneca. From 2005 to 2013, they were a Global Clinical Leader and PD Group Medical Director at Roche Pharmaceuticals. From 2013 to 2020, they were a SVP and Chief Medical Officer at The Medicines Company, as well as a Senior Vice President and Global Medical Leader Cardiovascular Care and Vice President and Global Medical Director. Since 2020, they have been a Chief Medical Officer at LIB Therapeutics and a Chief Scientific Officer at DalCor Pharmaceuticals.

David Kallend attended Chislehurst and Sidcup Grammar School from 1975 to 1982. David then attended Kings College London from 1982 to 1988, studying Medicine.